FDA Evaluating Metformin As a Life Extending Drug?

If one wants to live forever, one of the major impediments we must tackle is cancer, and Metformin may be able to offer protection against what has come to be known as the “Emperor of All Maladies.” Twenty-seven clinical trials, involving 24,000, patients proved the efficacy of Metformin in the fight against cancers of the colon and rectum. Cancer patients using the drug experienced a 42% higher survival rate than those patients not using Metformin. Similar results were observed in patients involved in prostate cancer studies. In recent years, these studies have increased to include cancers of seventeen different body organs, using 21 different species of mice and 4 species of rats.

WordPress SEO fine-tune by Meta SEO Pack from Poradnik Webmastera
Facebook
Facebook
Twitter
Visit Us